BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 8, 2009
View Archived Issues
Vanda Shares Surge 626% on FDA Approval of Fanapt
Shares in Vanda Pharmaceuticals Inc. rocketed into the stratosphere Thursday on news of the FDA's surprising approval of the company's antipsychotic Fanapt. (BioWorld Today)
Read More
HHS Officials Provide More Details on HHS FY 2010 Budget
Read More
Candidate Culprit for Multiple Sclerosis Gray Matter Damage
Read More
Zenobia Takes Up Arms Against Parkinson's, Other CNS Diseases
Read More
Licensing Deal Gives Pharma Firm Majority of Cornerstone
Read More
Financings Roundup
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Earnings Roundup
Read More